AHR and apparent mineralocorticoid excess: To investigate the mechanisms, the authors blocked AhR by either co-treating embryos with the AhR antagonist (CH223191) or by knocking down AhR2 by injecting AhR2-specific morpholino and treating the embryos with APE.